Skip to site alert.
Skip to content
Showing 1 - 10 of 200 results.
Here we characterize the inflammatory milieu that drives both niche and haematopoietic remodelling.
Two CSCI faculty members have received prestigious “New Innovator(” awards from the NIH’s High-Risk, High-Reward program.
This past August, after a two-year hiatus, Project Medical Education (PME) returned to Columbia University Irving Medical Center (CUIMC).
We provide a rich resource for dissecting the regulatory network that governs the developmental potency of EPSCs and exploring alternative strategies to capture totipotent stem cells in culture.
The Cancer Discovery Research award provides recipients with funding at $200,000 per year for up to three years.
Aaron Viny, MD, assistant professor of medicine at VP&S, joins 16 recipients recognized for research that has the potential to advance the prevention, diagnosis and treatment of human disease.
Here we describe a method for spatially resolved chromatin accessibility profiling of tissue sections using next-generation sequencing.
Discovery of the CRISPR-associated protein Cas9 and its RNA-guided cleavage mechanism marks the beginning of a new era in genomic engineering by enabling the editing of a target region in the genome.
Our results uncover a unifying stress-response pathway causally linking Aβ42o-dependent structural remodeling of dendritic mitochondria to synaptic loss.
Today Hynek Wichterle, PhD, and his colleagues are tantalizingly close to bringing a new drug for amyotrophic lateral sclerosis (ALS) to market.